Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,008 | 104,713 | 118,933 | 130,282 | 124,037 |
| Receivables | N/A | 79 | 79 | N/A | 5,000 |
| TOTAL | $138,811 | $106,105 | $120,417 | $131,298 | $129,971 |
| Non-Current Assets | |||||
| PPE Net | 1,177 | 1,141 | 886 | 549 | 443 |
| Other Non-Current Assets | 885 | 862 | 973 | 974 | 448 |
| TOTAL | $2,062 | $2,003 | $1,859 | $1,523 | $891 |
| Total Assets | $140,873 | $108,108 | $122,276 | $132,821 | $130,862 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,984 | 1,727 | 2,160 | 1,784 | 1,853 |
| Accrued Expenses | 11,534 | 10,821 | 8,789 | 6,084 | 3,862 |
| TOTAL | $14,330 | $13,363 | $11,770 | $8,691 | $6,544 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 812 | 815 | 821 | 823 | 829 |
| Other Non-Current Liabilities | 25,194 | 19,425 | 22,584 | 36,011 | 38,183 |
| TOTAL | $28,843 | $23,138 | $26,394 | $40,002 | $42,366 |
| Total Liabilities | $43,173 | $36,501 | $38,164 | $48,693 | $48,910 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 530 | 530 | 457 | 456 | 442 |
| Common Shares | 80 | 69 | 68 | 68 | 66 |
| Retained earnings | -212,062 | -187,592 | -174,348 | -173,546 | -162,822 |
| TOTAL | $97,700 | $71,607 | $84,112 | $84,128 | $81,952 |
| Total Liabilities And Equity | $140,873 | $108,108 | $122,276 | $132,821 | $130,862 |